Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Roderick Mcphee, MD
MedImmune LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
ACT, Australia
- Research Site
Liverpool, Australia
- Research Site
Woolloongabba, Australia
- Research Site
Surrey, British Columbia, Canada
- Research Site
Barrie, Ontario, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Berlin, Germany
- Research Site
Frankfurt am Main, Germany
- Research Site
Gera, Germany
- Research Site
Hanover, Germany
- Research Site
Leipzig, Germany
- Research Site
München, Germany
- Research Site
Münster, Germany
- Research Site
Debrecen, Hungary
- Research Site
Kaposvár, Hungary
- Research Site
Miskolc, Hungary
- Research Site
Pécs, Hungary
- Research Site
Szeged, Hungary
- Research Site
Szombathely, Hungary
- Research Site
Tauranga, New Zealand
- Research Site
Wellington, New Zealand
- Research Site
North Miami Beach, Florida, United States
- Research Site
Tampa, Florida, United States
- Research Site
Arlington Hts, Illinois, United States
- Research Site
Carmel, Indiana, United States
- Research Site
Indianapolis, Indiana, United States
- Research Site
Berlin, New Jersey, United States
- Research Site
Charlotte, North Carolina, United States
- Research Site
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2015
- Primary completion
- 9 May 2016
- Completion
- 15 Jul 2016
- Last update posted
- 15 Feb 2018
- Registered enrollment
- 113
- Registry id
- NCT02525094
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.